Cardiac Dimensions Obtains $15,200,000 New Financing

  • Feed Type
  • Date
    3/11/2015
  • Company Name
    Cardiac Dimensions
  • Mailing Address
    5540 Lake Washington Blvd. NE Kirkland, WA 98033 USA
  • Company Description
    Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of congestive heart failure (CHF) and related conditions.
  • Website
    http://www.cardiacdimensions.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds will be used to support the company’s REDUCE FMR clinical trial. REDUCE FMR is the first blinded, randomized clinical trial of a percutaneous mitral repair device in patients with functional mitral regurgitation (FMR). Involving up to 20 leading hospitals in Europe and Australia, REDUCE FMR is being initiated with the objective to establish CARILLON as the gold standard therapy in the treatment of FMR. The proceeds will also be used to expand the company’s research and development projects and its commercial operations.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy